Full Text Full Text (PDF) CME: Take the course for this article: AJP CME Course for March 2008: Augmentation of Behavior Therapy With D-Cycl... Alert me when this article is cited Alert me if a correction is posted Citation Map Email this article to a Colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Articles & Searches Download to citation manager Articles by Wilhelm, S. Articles by Rauch, S. L. PubMed Citation Articles by Wilhelm, S. Articles by Rauch, S. L. Obsessive-Compulsive Disorder Behavior Therapy Other Somatic Therapy Related Articles

Augmentation of Behavior Therapy With D-Cycloserine for Obsessive-Compulsive Disorder

OBJECTIVE: This study examined whether D-cycloserine, a partial agonist at the N-methyl-D-aspartate (NMDA) glutamatergic receptor, enhances the efficacy of behavior therapy for obsessive-compulsive disorder (OCD). METHOD: A randomized, double-blind, placebo-controlled trial investigating D-cycloserine versus placebo augmentation of behavior therapy was conducted in 23 OCD patients. Patients first underwent a diagnostic interview and pretreatment evaluation, followed by a psychoeducational/treatment planning session. Then they received 10 behavior therapy sessions. Treatment sessions were conducted twice per week. One hour before each of the behavior therapy sessions, the participants received either D-cycloserine, 100 mg, or a placebo. RESULTS: Relative to the placebo group, the D-cycloserine group’s OCD symptoms were significantly more improved at mid-treatment, and the D-cycloserine group’s depressive symptoms were significantly more improved at posttreatment. CONCLUSIONS: These data provide support for the use of D-cycloserine as an augmentation of behavior therapy for OCD and extend findings in animals and other human disorders suggesting that behavior therapy acts by way of long-term potentiation of glutamatergic pathways and that the effects of behavior therapy are potentiated by an NMDA agonist.

Related Articles:

Critical Parameters for D-Cycloserine Enhancement of Cognitive-Behaviorial Therapy for Obsessive-Compulsive Disorder

Barbara Olasov Rothbaum
Am J Psychiatry 2008 165: 293-296. [Full Text] [PDF]

Get information about faster international access.

Privacy Policy

Copyright © 2008 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us